Pharmafile Logo

Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy & Education, Public Relations & Policy, and Advertising, to create unique value with visionary clients.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

2 Television Centre, 101 Wood Lane, London, W12 9RF, UK
+44 (0)1753 833348

 Latest Content from PMHub 

Medscape Launches “Where Public Health Meets Practice” Learning Center to Translate Public Health Strategies into Patient Care

  The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...

Why stigma is a launch risk in rare disease – and what commercial leaders can do about it

Rare disease launches are complex by nature. Yet one of the most consistent risks we see is rarely treated as a launch issue at all: stigma.

From Static to Strategic: The 2026 Playbook for Longitudinal Pharma Interaction

Press Releases | February 26, 2026 | Impetus Digital

Stop pushing content at a burnt-out audience and start creating "Digital Magnetism." Join Impetus Digital to unlock the 2026 Engagement Toolkit—a deep dive into the immersive, longitudinal strategies and newly...

Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden

Press Releases | February 25, 2026 | Medscape Education

Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For...

T40: when a number is not just a number

Press Releases | February 23, 2026 | Grace Communications

Proud to be ranked 3rd among the Top 10 UK-focused agencies, along with other categories, Grace Communications finds inspiration in being included in PMLive’s Top 40 Creative Healthcare Agencies 2025.

Why patient engagement must come first in rare disease trials

Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.

New Cuttsy+Cuttsy research shows why site support matters more than ever

Press Releases | February 23, 2026 | Cuttsy + Cuttsy

Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...

#ShortenTheJourney

Press Releases | February 18, 2026 | Medscape Education

For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...

Why We Must Stop Normalizing the “Pregnancy Itch”

Press Releases | February 18, 2026 | Medscape Education

In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical...